Reviva Pharmaceuticals, Inc. — Form D
Reviva Pharmaceuticals, Inc. of SAN JOSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-25. The offering totals $15.8M, of which $15.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-06-25
- Form: D
- Accession: 0001552470-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $15.8M
- Amount sold: $15.8M
- Investors: 47
- Date of first sale: 2014-06-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-219817
Issuer
- Name: Reviva Pharmaceuticals, Inc.
- CIK: 0001552470
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5941 OPTICAL COURT, SAN JOSE, CA, 95138
- Phone: 408-960-2209
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Laxminarayan Bhat | Director | SAN JOSE, CA |
| Laxminarayan Bhat | Executive Officer | SAN JOSE, CA |
| Marc Cantillon | Executive Officer | Santa Clara, CA |
| Sarvajna Dwivedi | Director | Santa Clara, CA |
| Pedr Jensen | Director | Santa Clara, CA |
Other filings by this issuer (3)
More